1-18 of 18
Samuel Y. Ng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

Clinical Trials & Observations
Mwanasha H. Merrill, Parastoo B. Dahi, Robert A. Redd, Mikaela M. McDonough, Yi-Bin Chen, Zachariah DeFilipp, Alex F. Herrera, David C. Fisher, Ann S. LaCasce, Oreofe O. Odejide, Samuel Y. Ng, Caron A. Jacobson, Reid W. Merryman, Austin I. Kim, Yago L. Nieto, Craig S. Sauter, Gunjan L. Shah, Jasmine M. Zain, Philippe Armand, Eric D. Jacobsen
Journal: Blood
Blood (2023) 142 (7): 621–628.
https://doi.org/10.1182/blood.2023020244
Published: 2023
Journal Articles

Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1

Wenchao Wu, Geoffrey M. Nelson, Raphael Koch, Katherine A. Donovan, Radosław P. Nowak, Tayla B. Heavican-Foral, Ajit J. Nirmal, Huiyun Liu, Lei Yang, Jessica Duffy, Foster Powers, Kristen E. Stevenson, Marcus Kenneth Jones, Samuel Y. Ng, Gongwei Wu, Salvia Jain, Ran Xu, Sam Amaka, Christopher Trevisani, Nicholas L. Donaldson, Patrick R. Hagner, Laurence de Leval, Philippe Gaulard, Javeed Iqbal, Anjan Thakurta, Eric S. Fischer, Karen Adelman, David M. Weinstock
Journal: Blood
Blood (2022) 139 (13): 2024–2037.
https://doi.org/10.1182/blood.2021014701
Published: 2022
Includes: Supplemental data
Journal Articles

Prognostic Value of Minimal Residual Disease (MRD) Among Patients with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

Eleanor Taranto, Robert A. Redd, Erin Jeter, Kristin M McHugh, Jennifer R Brown, Jennifer L. Crombie, Matthew S. Davids, David C. Fisher, Arnold S. Freedman, Eric D Jacobsen, Caron Jacobson, Austin I. Kim, Ann S. LaCasce, Benjamin L. Lampson, Samuel Y. Ng, Oreofe O. Odejide, Erin Michelle Parry, Parastoo B. Dahi, Yago Nieto, Robin M. Joyce, Yi-Bin Chen, Alex F. Herrera, Philippe Armand, Reid W Merryman
Journal: Blood
Blood (2021) 138 (Supplement 1): 3491.
https://doi.org/10.1182/blood-2021-147263
Published: 2021
Journal Articles

Longer Term Follow-up of a Multicenter, Phase 2 Study of Ibrutinib Plus Fludarabine, Cyclophosphamide, Rituximab (iFCR) As Initial Therapy for Younger Patients with Chronic Lymphocytic Leukemia

Matthew S. Davids, Danielle M. Brander, Svitlana Tyekucheva, Chinheng Chen, James Kaminski, Josie Montegaard, Alvaro J. Alencar, Leyla Shune, Mohammad Omaira, Caron Jacobson, Philippe Armand, Samuel Y. Ng, Jennifer L. Crombie, Ann S. LaCasce, Jon E. Arnason, Ephraim Hochberg, Ronald W. Takvorian, Jeremy S. Abramson, David C. Fisher, Jennifer R Brown
Journal: Blood
Blood (2021) 138 (Supplement 1): 640.
https://doi.org/10.1182/blood-2021-146624
Published: 2021
Journal Articles

Interim Positron Emission Tomography (iPET) Assessed Using Deauville Score for Patients with Follicular Lymphoma Receiving First-Line Chemoimmunotherapy

Reid W Merryman, MD, Gabriela Spilberg, MD, Patrizia Mondello, MDPhDMSc, Robert A. Redd, MS, Eleanor Taranto, MD, Gulrayz Ahmed, MD, Erin Jeter, Matthew Chase, MD, Gilles Salles, MDPhD, Andrew D Zelenetz, MD PhD, Jennifer R Brown, MD PhD, Jennifer Crombie, MD, Matthew S. Davids, MD, David C. Fisher, MD, Arnold S. Freedman, MD, Eric D Jacobsen, MD, Caron A. Jacobson, MD, Austin I. Kim, MD, Ann S. LaCasce, MD MSc, Benjamin L. Lampson, MD PhD, Samuel Y. Ng, MDPhD, Oreofe Odejide, MD, Philippe Armand, MD PhD, Heather A. Jacene, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-135919
Published: 2020
Journal Articles

Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions

Brief Report
Noriaki Yoshida, Kay Shigemori, Nicholas Donaldson, Christopher Trevisani, Nicolas A. Cordero, Kristen E. Stevenson, Xia Bu, Fumiko Arakawa, Mai Takeuchi, Koichi Ohshima, Akinori Yoda, Samuel Y. Ng, David M. Weinstock
Journal: Blood
Blood (2020) 135 (17): 1467–1471.
https://doi.org/10.1182/blood.2019001815
Published: 2020
Includes: Supplemental data
Journal Articles

Genomic Landscape of Young ATLL Patients Identifies Frequent Targetable CD28 Fusions

Noriaki Yoshida, MD PhD, Kay Shigemori, Samuel Y. Ng, MD PhD, Ajit Nirmal, PhD, Nicolas Donaldson, Nicolas Cordero, Kristen E. Stevenson, MS, Xia Bu, Mai Takeuchi, MD PhD, Koichi Ohshima, MD PhD, Akinori Yoda, PhD, David M Weinstock
Journal: Blood
Blood (2019) 134 (Supplement_1): 2760.
https://doi.org/10.1182/blood-2019-122525
Published: 2019
Journal Articles

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

Clinical Trials & Observations
Philippe Armand, Yi-Bin Chen, Robert A. Redd, Robin M. Joyce, Jad Bsat, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman, Parastoo B. Dahi, Yago Nieto, Ann S. LaCasce, David C. Fisher, Samuel Y. Ng, Oreofe O. Odejide, Arnold S. Freedman, Austin I. Kim, Jennifer L. Crombie, Caron A. Jacobson, Eric D. Jacobsen, Jeffrey L. Wong, Sanjay S. Patel, Jerome Ritz, Scott J. Rodig, Margaret A. Shipp, Alex F. Herrera
Journal: Blood
Blood (2019) 134 (1): 22–29.
https://doi.org/10.1182/blood.2019000215
Published: 2019
Journal Articles

PD-1 Blockade for Diffuse Large B-Cell Lymphoma after Autologous Stem Cell Transplantation

Yi-Bin Chen, MD, Philippe Armand, MD PhD, Robert A. Redd, MS, Jad Bsat, BA, Reid W Merryman, MD, Kimberly Coleman, RN, Alex F. Herrera, MD, Parastoo B. Dahi, MD, Yago Nieto, MD PhD, Ann S. LaCasce, MD MSc, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Oreofe O. Odejide, MD, Arnold S. Freedman, MD, Austin I Kim, MD, Jennifer L Crombie, MD, Caron A. Jacobson, MD, Eric D Jacobsen, MD, Jeffrey L Wong, MD PhD, Sanjay S Patel, MD MSc, MPH, Jerome Ritz, MD PhD, Scott J Rodig, MDPhD, Margaret A. Shipp, MD, Robin M. Joyce, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 706.
https://doi.org/10.1182/blood-2018-99-114914
Published: 2018
Journal Articles

PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation

Philippe Armand, MD PhD, Yi-Bin Chen, MD, Robert A. Redd, MS, Robin M. Joyce, MD, Jad Bsat, BA, Reid W Merryman, MD, Kimberly Coleman, RN, Parastoo B. Dahi, MD, Yago Nieto, MD PhD, Ann S. LaCasce, MD MSc, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Oreofe O. Odejide, MD, Arnold S. Freedman, MD, Austin I Kim, MD, Jennifer L Crombie, MD, Caron A. Jacobson, MD, Eric D Jacobsen, MD, Jeffrey L Wong, MD PhD, Mikel Lipschitz, M.S., Sanjay S Patel, MD MSc, MPH, Jerome Ritz, MD PhD, Scott J Rodig, MDPhD, Margaret A. Shipp, MD, Alex F Herrera, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1650.
https://doi.org/10.1182/blood-2018-99-113685
Published: 2018
Journal Articles

Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Phase 2 Clinical Trials and Off-Trial Experience

Reid W Merryman, MD, Brad S Kahl, MD, Robert A. Redd, MS, Jad Bsat, BA, Matthew Lewis Chase, Ann S. LaCasce, MD MSc, Arnold S. Freedman, MD, Caron A. Jacobson, MD, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Jennifer L Crombie, MD, Austin I Kim, MD, Oreofe O. Odejide, MD, Matthew S. Davids, MD, Jennifer R. Brown, MD PhD, Heather A. Jacene, Mehta-Shah Neha, Natasha Edwin, MD, Amanda F Cashen, MD, Nancy L. Bartlett, MD, Armin Ghobadi, MD, Philippe Armand, MD PhD, Robin M. Joyce, MD, Eric D Jacobsen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 145.
https://doi.org/10.1182/blood-2018-99-110520
Published: 2018
Journal Articles

RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice

Samuel Y. Ng, Leon Brown, Kristen Stevenson, Tiffany deSouza, Jon C. Aster, Abner Louissaint, Jr, David M. Weinstock
Journal: Blood
Blood (2018) 132 (9): 935–947.
https://doi.org/10.1182/blood-2017-11-818617
Published: 2018
Includes: Supplemental data
Journal Articles

A Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients

Matthew S. Davids, MD, Haesook T Kim, PhD, Danielle M. Brander, MD, Jad Bsat, BA, Alexandra Savell, BS, Karen Francoeur, RN, Caron Jacobson, MD, Samuel Y. Ng, MDPhD, Ann S LaCasce, MD MSc, Ephraim P. Hochberg, MD, Ronald W. Takvorian, MD, Jeremy S. Abramson, MD MMSc, David C. Fisher, MD PhD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 496.
https://doi.org/10.1182/blood.V130.Suppl_1.496.496
Published: 2017
Journal Articles

In Vitro andpre-Clinical In Vivo evidence Support MDMX/MDM2 As Common Vulnerabilities across TP53 -Wild-Type T-Cell Lymphomas That Are Targetable with the α-Helical p53 Stapled Peptide Alrn-6924

Raphael Koch, MD, Amanda L Christie, BS, Noriaki Yoshida, MD PhD, Samuel Y. Ng, MDPhD, Kay Shigemori, Sara N Morrow, Alexandria Van Scoyk, Steven M. Horwitz, MD, Eric Jacobsen, MD, Solimar Santiago, Jian-Guo Ren, Vincent Guerlavais, PhD, D. Allan Annis, Manuel A. Aivado, MD PhD, David M. Weinstock, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 571.
https://doi.org/10.1182/blood.V130.Suppl_1.571.571
Published: 2017
Journal Articles

Generation and Application of T-Cell Lymphoma Patient Derived Tumor Xenograft Models

Danilo Fiore, PhD, Xujun Wang, Inna Khodos, Filomena Di Giacomo, PhD, Marcello Gaudiano, BS, Jude M Phillip, DPhil, Rui Wang, Zhiwei Yang, Michael Ginsberg, Andrew M Intlekofer, MD PhD, Craig B. Thompson, MD, Jon C. Aster, MD PhD, Jia Ruan, MD PhD, Samuel Y. Ng, MDPhD, Eric Jacobsen, MD, Ahmet Dogan, MD PhD, Elisa de Stanchina, Marissa Mattar, Leandro Cerchietti, MD, Rohan Bareja, Olivier Elemento, PhD, Wayne Tam, MD PhD, David M. Weinstock, MD, Shahin Rafii, MD, Steven M. Horwitz, MD, Giorgio Inghirami, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 109.
https://doi.org/10.1182/blood.V130.Suppl_1.109.109
Published: 2017
Journal Articles

Exploring RhoA G17V-Mediated T-Cell Dysfunction

Samuel Y. Ng, MD PhD, Leon Brown, Tiffany DeSouza, Abner Louissaint, Jr., MD PhD, David M. Weinstock, MD
Journal: Blood
Blood (2016) 128 (22): 1567.
https://doi.org/10.1182/blood.V128.22.1567.1567
Published: 2016
Journal Articles

T-Cell Lymphoma Patient-Derived Xenografts and Newly Developed Cell Lines Recapitulate Aspects of Disease Biology and Represent Novel Tools for Preclinical Drug Development

Amanda L. Christie, BS, Samuel Y. Ng, MD PhD, Raphael Koch, MD, Alexandra N. Christodoulou, M.S., Tiffany DeSouza, Mark A. Murakami, MD MA, Moony Tseng, Anson Peng, Vadim Molla, Caron A. Jacobson, MD, Brent Shoji, MD, Nicole R. LeBoeuf, MD, Monica Bertagnolli, MD, Philippe Armand, MD PhD, Geraldine S Pinkus, MD, Jesse Boehm, PhD, Margaret A. Shipp, MD, David M. Dorfman, MD PhD, Eric D. Jacobsen, MD, David C. Fisher, MD, Elizabeth A. Morgan, MD, Jon C. Aster, MD PhD, David M. Weinstock, MD
Journal: Blood
Blood (2016) 128 (22): 3015.
https://doi.org/10.1182/blood.V128.22.3015.3015
Published: 2016
Journal Articles

B and T-Cell Lymphoma Patient-Derived Xenografts Recapitulate Aspects of Disease Biology and Progression and Represent Novel Tools for Preclinical Drug Development

Amanda L Christie, B.S., Alexandra N. Christodoulou, M.S., Tiffany DeSouza, B.S., Mark A. Murakami, MD MA, Loretta S. Li, MD, Nadja Kopp, M.S., Raphael Koch, MD, Abner Louissaint, Jr., MD PhD, Samuel Y. Ng, MD PhD, Caron A. Jacobson, MD, Brent Shoji, MD, Matthew S. Davids, MD, Oreofe O. Odejide, MD, Ann S. LaCasce, MD, David C. Fisher, MD, Arnold S. Freedman, MD, Eric D. Jacobsen, MD, Monica Bertagnolli, MD, Geraldine S Pinkus, MD, David M. Dorfman, MD PhD, Elizabeth A. Morgan, MD, Jon C Aster, MDPhD, Margaret A. Shipp, MD, David M. Weinstock
Journal: Blood
Blood (2015) 126 (23): 4001.
https://doi.org/10.1182/blood.V126.23.4001.4001
Published: 2015